• ¾ÆÁ¨´Ù
    • ÇÁ·Î±×·¥
    • ¿¬»ç
    • ±âÁ¶ °­¿¬
    • ´ë±â¾÷ÀÇ ¹ßÇ¥
    • ¼îÆ®ÄÚ½º
    • Æ®·¹ÀÌ´× ¼¼¹Ì³ª
    • Âü°¡ÀÚ
  • ½ºÆù¼­/Àü½Ã±â¾÷
    • ½ºÆù¼­
    • Àü½Ã±â¾÷ Ç÷ξîÇ÷£
  • °³ÃÖÁö
  • Æ÷½ºÅÍ ¹ßÇ¥
  • ¹®ÀÇ
  • Âü°¡½Åû
PEGS Summit Europe

¡°À¯·´ ÃÖ°íÀÇ »ý¹°Á¦Á¦ ±â¼ú ÄÁÆÛ·±½º¡±

ÄÁÆÛ·±½º ÇÁ·Î±×·¥

Engineering
  • Display of Biologics
    »ý¹°Á¦Á¦ÀÇ Àü½Ã
  • Engineering Antibodies
    Ç×üÀÇ ¿£Áö´Ï¾î¸µ
  • Machine Learning: Part 2
    ±â°èÇнÀ(ÆÄÆ® 2)
Targets
  • Antibody-Based Therapies
    Ç×ü ±â¹Ý Ä¡·á¹ý
  • Emerging Targets & Approaches
    »õ·Î¿î Ç¥Àû°ú ¾îÇÁ·ÎÄ¡
  • Membrane Protein Targets
    ¸·´Ü¹éÁú Ç¥Àû

Bispecifics
  • Safety & Efficacy
    ¾ÈÀü¼º°ú È¿´É
  • Advancing Multispecifics
    ´ÙÁ߯¯À̼ºÇ×üÀÇ Áøº¸
  • Engineering Bispecifics
    ÀÌÁ߯¯À̼ºÇ×üÀÇ ¿£Áö´Ï¾î¸µ
Immunotherapy
  • Modulating the TME
    TME(Á¾¾ç ¹Ì¼¼È¯°æ)ÀÇ Á¶Àý
  • Innovative CAR T Therapy
    Çõ½ÅÀûÀÎ CAR-T ¿ä¹ý
  • Next-Gen Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á
Analytical
  • Optimisation & Developability
    ÃÖÀûÈ­¿Í ¹ßÀü¼º
  • Analytical Characterisation
    ºÐ¼® Ư¼º Æò°¡
  • Protein Stability & Formulation
    ´Ü¹éÁú ¾ÈÁ¤¼º°ú ¹èÇÕ
Expression
  • Data Science & Engineering
    µ¥ÀÌÅÍ »çÀÌ¾ð½º¿Í ¿£Áö´Ï¾î¸µ
  • Optimising Expression
    ¹ßÇöÀÇ ÃÖÀûÈ­
  • Process Development
    ÇÁ·Î¼¼½º °³¹ß
Machine Learning
  • Intro to Machine Learning
    ±â°èÇнÀ ÀÔ¹®
  • Machine Learning: Part 1
    ±â°èÇнÀ(ÆÄÆ® 1)
  • Machine Learning: Part 2
    ±â°èÇнÀ(ÆÄÆ® 2)
Oncology
  • Antibody-Based Therapies
    Ç×ü ±â¹Ý ¿ä¹ý
  • Engineering Conjugates
    º¹ÇÕüÀÇ ¿£Áö´Ï¾î¸µ
  • Next-Gen Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á
Short Courses

Training Seminars
Catalog Download
Catalog

CHI | Cambridge HealthTech Institute


Çѱ¹¾î °ø½Ä»çÀÌÆ® ¿î¿µ : Cambridge Healthtech Institute ÆÄÆ®³Ê (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç